Archives of Gynecology and Obstetrics

, Volume 252, Issue 4, pp 185–189 | Cite as

Maternal serum CA125 levels in early intrauterine and tubal pregnancies

  • F. Kobayashi
  • E. Takashima
  • N. Sagawa
  • T. Mori
  • S. Fujii
Originals

Summary

Using an immunoradiometric assay, serum CA125 levels were measured in 13 women with a normal pregnancy, 9 with a spontaneous abortion, 3 with a hydatidiform mole, and 15 with a tubal pregnancy. Serum CA125 levels were high in patients with a normal pregnancy (154±169 U/ml; mean±S.D.), a spontaneous abortion (244±258 U/ml), or a hydatidiform mole (54±16 U/ml). In contrast, CA125 levels in patients with a tubal pregnancy (33±25 U/ml) were low, and almost all of those without uterine bleeding (25±9 U/ml) were within the normal range for non-pregnant women (<35 U/ml). The difference between serum CA125 levels with intrauterine pregnancy and with tubal pregnancy may be ascribed to the difference of the amount of decidual tissues at the site of trophoblastic invasion.

Key words

CA125 Pregnancy Ectopic pregnancy Abortion Decidua 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barbati A, Anceschi MM, Albert P, Pomili G, Di Renzo GC Cosmi EV (1989) Ontogeny of CA125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membrances. Am J Obstet Gynecol 160:514–517PubMedGoogle Scholar
  2. Bast RC Jr, Klug TL, John ES, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths T, Parker L, Zurawski VR, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887PubMedCrossRefGoogle Scholar
  3. Brusted JR, Nakajima ST, Badger G, Riddick DH, Gibson M (1990) Serum concentration of CA125 during the first trimester of normal and abnormal pregnancies. J Reprod Med 35:499–502Google Scholar
  4. Check JH, Nowroozi K, Winkel CA, Johnson T, Seefried L (1990) Serum CA125 levels in early pregnancy and subsequent spontaneous abortion. Obstet Gynecol 75:742–744PubMedGoogle Scholar
  5. Fujii S, Konishi I, Nanbu Y, Nonogaki H, Kobayashi F, Sagawa N, Mori T, Endo K (1988) Analysis of the levels of CA125, Carcinoembryonic Antigen, and CA19-9 in the cervical mucus for detection of cervical adenocarcinoma. Cancer 62:541–547PubMedGoogle Scholar
  6. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB (1984) Tissue distribution of a coelomic epithelial related antigen recognized by the monoclonal antibody CA125. Int J Gynecol Pathol 2:275–285CrossRefGoogle Scholar
  7. Kobayashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T (1989a) Mechanism and clinical significance of elevated CA125 levels in the sera of pregnant women. Am J Obstet Gynecol 160:563–566PubMedGoogle Scholar
  8. Kobayashi F, Sagawa N, Nanbu Y, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T (1989b) Immunohistochemical localizations and tissue levels of tumor-associated glycoprotein CA125 and CA19-9 in the decidua and fetal membranes at various gestational. ages. Am J Obstet Gynecol 160:1232–1238PubMedGoogle Scholar
  9. Niloff JM, Klug TL, Schaetzl E, Zurawski VR Jr, Knapp RC, Bast RC Jr (1984a) Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol 148:1057–1058PubMedGoogle Scholar
  10. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast Jr (1984b) CA125 antigen levels in obstetrics and gynecologic patients. Obstet Gynecol 64:703–707PubMedGoogle Scholar
  11. O'Brien TJ, Hardin JW, Bannon GA, Norris JS, Quirk JG (1986) CA125 antigen in human amniotic fluid and fetal membranes. Am J Obstet Gynecol 155:50–55PubMedGoogle Scholar
  12. Quirk JG, Brunson GL, Long CA, Bannon GA, Sanders MM, O'Brien TJ (1988) CA125 in tissues and amniotic fluid during pregnancy. Am J Obstet Gynecol 159:644–649PubMedGoogle Scholar
  13. Witt BR, Wolf GC, Wainwright CJ, Johnston PD, Thorneycroft IH (1990) Relaxin, CA125, progesterone, estradiol, Schwangerschaft protein, and human chorionic gonadotropin as predictors of outcome in threatened and nonthreatened pregnancies. Fertil Steril 53:1029–1036PubMedGoogle Scholar
  14. Witt BR, Miles R, Wolf GC, Koulianos GT, Thorneycroft IH (1991) CA125 levels in abruptio placentae. Am J Obstet Gynecol 164:1225–1228PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • F. Kobayashi
    • 1
  • E. Takashima
    • 1
  • N. Sagawa
    • 3
  • T. Mori
    • 3
  • S. Fujii
    • 2
  1. 1.Department of Obstetrics and GynecologyKobe Central Municipal HospitalKobeJapan
  2. 2.Department of Obstetrics and Gynecology, Faculty of MedicineShinshu UniversityMatsumotoJapan
  3. 3.Department of Gynecology and Obstetrics, Faculty of MedicineKyoto UniversityKyotoJapan

Personalised recommendations